These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 38707399)

  • 1. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear medicine imaging of lung cancer.
    Goldsmith SJ; Kostakoglu L
    Radiol Clin North Am; 2000 May; 38(3):511-24. PubMed ID: 10855258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-day examination of triple nuclear medicine imaging and application in evaluating transarterial embolization.
    Du N; Jia G; Zhang W; Tong Q; Qu X; Liu R; Li D; Yan Z; Zuo C; Li X; Li R; Zhang W
    Heliyon; 2024 May; 10(9):e29597. PubMed ID: 38707399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Rep S; Hocevar M; Vaupotic J; Zdesar U; Zaletel K; Lezaic L
    J Radiol Prot; 2018 Mar; 38(1):343-356. PubMed ID: 29339573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of
    Wu Y; Wang Y; Yang Z; Teng C; Guo Z
    Thorac Cancer; 2022 Nov; 13(21):3025-3031. PubMed ID: 36104010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Radiation Exposure Dose for Nuclear Medicine Workers from
    Al-Esaei AM; Khalil MM; El Shazly RM; Kany AMI; Saleh EE; Elmaghraby S
    Curr Radiopharm; 2022; 15(4):320-326. PubMed ID: 35422232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Tracer PET/CT Protocol with [
    Roth KS; Voltin CA; van Heek L; Wegen S; Schomäcker K; Fischer T; Marnitz S; Drzezga A; Kobe C
    J Nucl Med; 2022 Nov; 63(11):1683-1686. PubMed ID: 35422446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
    Cascone T; Weissferdt A; Godoy MCB; William WN; Leung CH; Lin HY; Basu S; Yadav SS; Pataer A; Mitchell KG; Khan MAW; Shi Y; Haymaker C; Solis LM; Parra ER; Kadara H; Wistuba II; Sharma P; Allison JP; Ajami NJ; Wargo JA; Jenq RR; Gibbons DL; Lee JJ; Swisher SG; Vaporciyan AA; Heymach JV; Sepesi B
    Nat Commun; 2021 Aug; 12(1):5045. PubMed ID: 34413300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor.
    Queiroz MM; Lopes CDH; Salgues ACR; Barbosa FG; Abe ES; Silveira TP; Machado MCC; Capareli FC
    Eur J Hybrid Imaging; 2021 May; 5(1):9. PubMed ID: 34181108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atezolizumab and bevacizumab for hepatocellular carcinoma: mechanism, pharmacokinetics and future treatment strategies.
    Liu X; Lu Y; Qin S
    Future Oncol; 2021 Jun; 17(17):2243-2256. PubMed ID: 33663220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer.
    Santos A; Mattiolli A; Carvalheira JB; Ferreira U; Camacho M; Silva C; Costa F; Matheus W; Lima M; Etchebehere E
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):493-500. PubMed ID: 32789680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication of suitable transarterial chemoembolization and multikinase inhibitors for intermediate stage hepatocellular carcinoma.
    Shimose S; Kawaguchi T; Iwamoto H; Niizeki T; Shirono T; Tanaka M; Koga H; Torimura T
    Oncol Lett; 2020 Apr; 19(4):2667-2676. PubMed ID: 32218817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ImmunoPET: Concept, Design, and Applications.
    Wei W; Rosenkrans ZT; Liu J; Huang G; Luo QY; Cai W
    Chem Rev; 2020 Apr; 120(8):3787-3851. PubMed ID: 32202104
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.